A P Athanasoulia

Summary

Affiliation: Max Planck Institute of Psychiatry
Country: Germany

Publications

  1. ncbi request reprint The effect of the ANKK1/DRD2 Taq1A polymorphism on weight changes of dopaminergic treatment in prolactinomas
    A P Athanasoulia
    Department of Internal Medicine, Endocrinology and Clinical Chemistry, Max Planck Institute of Psychiatry, Kraepelinstrasse 2 10, 80804, Munich, Germany
    Pituitary 17:240-5. 2014
  2. doi request reprint Rare missense P450c17 (CYP17A1) mutation in exon 1 as a cause of 46,XY disorder of sexual development: implications of breast tissue 'unresponsiveness' despite adequate estradiol substitution
    A P Athanasoulia
    Department of Internal Medicine, Endocrinology and Clinical Chemistry, Max Planck Institute of Psychiatry, Munich, Germany
    Sex Dev 7:212-5. 2013
  3. doi request reprint Distinct dopaminergic personality patterns in patients with prolactinomas: a comparison with nonfunctioning pituitary adenoma patients and age- and gender-matched controls
    A P Athanasoulia
    Department of Internal Medicine, Endocrinology and Clinical Chemistry, Max Planck Institute of Psychiatry, Munich, Germany
    Neuroendocrinology 96:204-11. 2012
  4. doi request reprint Polymorphisms of the drug transporter gene ABCB1 predict side effects of treatment with cabergoline in patients with PRL adenomas
    A P Athanasoulia
    Department of Internal Medicine, Max Planck Institute of Psychiatry, Kraepelinstrasse 2 10, 80804 Munich, Germany
    Eur J Endocrinol 167:327-35. 2012
  5. ncbi request reprint IGF-I levels and depressive disorders: Results from the Study of Health in Pomerania (SHIP)
    C Sievers
    Max Planck Institute of Psychiatry, Kraepelinstr 2 10, 80804 Munich, Germany Electronic address
    Eur Neuropsychopharmacol 24:890-6. 2014

Collaborators

Detail Information

Publications5

  1. ncbi request reprint The effect of the ANKK1/DRD2 Taq1A polymorphism on weight changes of dopaminergic treatment in prolactinomas
    A P Athanasoulia
    Department of Internal Medicine, Endocrinology and Clinical Chemistry, Max Planck Institute of Psychiatry, Kraepelinstrasse 2 10, 80804, Munich, Germany
    Pituitary 17:240-5. 2014
    ..However, there was no association to the A1 allele of Taq1A, observation that needs to be analysed in larger cohorts. ..
  2. doi request reprint Rare missense P450c17 (CYP17A1) mutation in exon 1 as a cause of 46,XY disorder of sexual development: implications of breast tissue 'unresponsiveness' despite adequate estradiol substitution
    A P Athanasoulia
    Department of Internal Medicine, Endocrinology and Clinical Chemistry, Max Planck Institute of Psychiatry, Munich, Germany
    Sex Dev 7:212-5. 2013
    ..This phenomenon could be attributed to irreversible breast tissue alterations following high serum progesterone levels...
  3. doi request reprint Distinct dopaminergic personality patterns in patients with prolactinomas: a comparison with nonfunctioning pituitary adenoma patients and age- and gender-matched controls
    A P Athanasoulia
    Department of Internal Medicine, Endocrinology and Clinical Chemistry, Max Planck Institute of Psychiatry, Munich, Germany
    Neuroendocrinology 96:204-11. 2012
    ..Hence, we aimed at examining whether patients with prolactinomas exhibit modified personality patterns compared to patients with nonfunctioning pituitary adenomas and healthy controls...
  4. doi request reprint Polymorphisms of the drug transporter gene ABCB1 predict side effects of treatment with cabergoline in patients with PRL adenomas
    A P Athanasoulia
    Department of Internal Medicine, Max Planck Institute of Psychiatry, Kraepelinstrasse 2 10, 80804 Munich, Germany
    Eur J Endocrinol 167:327-35. 2012
    ..Central side effects may depend on a substance's ability to pass the blood-brain barrier, which can be actively controlled by transporter molecules such as the P-glycoprotein (P-gp) encoded by the ABCB1 gene...
  5. ncbi request reprint IGF-I levels and depressive disorders: Results from the Study of Health in Pomerania (SHIP)
    C Sievers
    Max Planck Institute of Psychiatry, Kraepelinstr 2 10, 80804 Munich, Germany Electronic address
    Eur Neuropsychopharmacol 24:890-6. 2014
    ..002) than those within the 10th-90th percentile. In conclusion we can demonstrate that low IGF-I levels in females and high IGF-I levels in males predict the development of depressive disorders in this general adult population sample. ..